• 9231 Citations
  • 38 h-Index
1987 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Outputs

Filter
Article

Abiraterone alone or in combination with enzalutamide in metastatic castration-resistant prostate cancer with rising prostate-specific antigen during enzalutamide treatment

Attard, G., Borre, M., Gurney, H., Loriot, Y., Andresen-Daniil, C., Kalleda, R., Pham, T., Taplin, M. E. & on behalf of PLATO collaborators, 1 Sep 2018, In : Journal of Clinical Oncology. 36, 25, p. 2639-2646 8 p.

Research output: Contribution to journalArticle

Open Access
File
30 Citations (Scopus)
11 Downloads (Pure)

Accelerated BEP for metastatic germ cell tumours: A multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Grimison, P. S., Stockler, M. R., Chatfield, M., Thomson, D. B., Gebski, V., Friedlander, M., Boland, A. L., Houghton, B., Gurney, H., Rosenthal, M., Singhal, N., Kichenadasse, G., Wong, S. S., Lewis, C. R., Vasey, P. A. & Toner, G. C., Jan 2014, In : Annals of Oncology. 25, 1, p. 143-148 6 p., mdt369.

Research output: Contribution to journalArticle

20 Citations (Scopus)

A cost-utility approach to the use of 5-fluorouracil and levamisole ad adjuvant chemotherapy for Dukes' C colonic carcinoma

Smith, R. D., Hall, J., Gurney, H. & Harnett, P. R., 1993, In : Medical Journal of Australia. 158, 5, p. 319-320 2 p.

Research output: Contribution to journalArticle

35 Citations (Scopus)

A Distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer

PRIMe Consortium, 15 Nov 2017, In : International Journal of Cancer. 141, 10, p. 2112-2120 9 p.

Research output: Contribution to journalArticle

12 Citations (Scopus)

Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer

Spry, N. A., Kristjanson, L., Hooton, B., Hayden, L., Neerhut, G., Gurney, H., Corica, T., Korbel, E., Weinstein, S. & McCaul, K., May 2006, In : European Journal of Cancer. 42, 8, p. 1083-1092 10 p.

Research output: Contribution to journalArticle

92 Citations (Scopus)

An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancer

Pezaro, C., Rosenthal, M. A., Gurney, H., Davis, I. D., Underhill, C., Boyer, M. J., Kotasek, D., Solomon, B. & Toner, G. C., Aug 2009, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 32, 4, p. 338-341 4 p.

Research output: Contribution to journalArticle

40 Citations (Scopus)

A phase II study of ifosfamide and a2b-interferon in advanced non-small-cell lung cancer

Lind, M. J., Gomm, S., Simmonds, A. P., Ashcroft, L., Kamthan, A., Gurney, H. & Thatcher, N., Mar 1991, In : Cancer Chemotherapy and Pharmacology. 28, 2, p. 142-144 3 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

A phase II trial of paclitaxel and epirubicin in advanced breast cancer

Rischin, D., Smith, J., Millward, M., Lewis, C., Boyer, M., Richardson, G., Toner, G., Gurney, H. & McKendrick, J., 2000, In : British Journal of Cancer. 83, 4, p. 438-442 5 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)

A potent liver-mediated mechanism for loss of muscle mass during androgen deprivation therapy

Lam, T., McLean, M., Hayden, A., Poljak, A., Cheema, B., Gurney, H., Stone, G., Bahl, N., Reddy, N., Shahidipour, H. & Birzniece, V., 1 May 2019, In : Endocrine Connections. 8, 5, p. 605-615 11 p.

Research output: Contribution to journalArticle

Open Access
File
6 Downloads (Pure)

A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer

Sternberg, C. N., Saad, F., Graff, J. N., Peer, A., Vaishampayan, U. N., Leung, E., Rosenbaum, E., Gurney, H., Epstein, R. J., Davis, I. D., Wu, B., Trandafir, L., Wagner, V. J. & Hussain, M., 1 Feb 2020, In : Annals of Oncology. 31, 2, p. 257-265 9 p.

Research output: Contribution to journalArticle

Open Access
File
1 Citation (Scopus)
1 Downloads (Pure)

A randomized study of paclitaxel versus cyclophosphamide/methotrexate/- fluorouracil/prednisone in previously untreated patients with advanced breast cancer: Preliminary results

Bishop, J. F., Dewar, J., Toner, G., Tattersall, M. H., Olver, I., Ackland, S., Kennedy, I., Goldstein, D., Gurney, H., Walpole, E., Levi, J. & Stephenson, J., 1997, In : Seminars in Oncology. 24, 5 SUPPL. 17, p. S17-5-S17-9 5 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)

A second Australian family with hemoglobin north shore (β134 val→glu)

Gurney, H., Baig, I., Gordon, S., Phadke, K., Kearsley, H., Fleming, P., Wyatt, K. & Hughes, W., 1987, In : Pathology. 19, 1, p. 62-63 2 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Association analysis of genetic polymorphisms in genes related to sunitinib pharmacokinetics, specifically clearance of sunitinib and SU12662

Diekstra, M. H. M., Klümpen, H. J., Lolkema, M. P. J. K., Yu, H., Kloth, J. S. L., Gelderblom, H., Van Schaik, R. H. N., Gurney, H., Swen, J. J., Huitema, A. D. R., Steeghs, N. & Mathijssen, R. H. J., 2014, In : Clinical Pharmacology and Therapeutics. 96, 1, p. 81-89 9 p.

Research output: Contribution to journalArticle

52 Citations (Scopus)

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

Rini, B. I., Powles, T., Atkins, M. B., Escudier, B., McDermott, D. F., Suarez, C., Bracarda, S., Stadler, W. M., Donskov, F., Lee, J. L., Hawkins, R., Ravaud, A., Alekseev, B., Staehler, M., Uemura, M., De Giorgi, U., Mellado, B., Porta, C., Melichar, B., Gurney, H. & 12 others, Bedke, J., Choueiri, T. K., Parnis, F., Khaznadar, T., Thobhani, A., Li, S., Piault-Louis, E., Frantz, G., Huseni, M., Schiff, C., Green, M. C. & Motzer, R. J., 15 Jun 2019, In : The Lancet. 393, 10189, p. 2404-2415 12 p.

Research output: Contribution to journalArticle

131 Citations (Scopus)

Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma

Motzer, R. J., Penkov, K., Haanen, J., Rini, B., Albiges, L., Campbell, M. T., Venugopal, B., Kollmannsberger, C., Negrier, S., Uemura, M., Lee, J. L., Vasiliev, A., Miller, W. H., Gurney, H., Schmidinger, M., Larkin, J., Atkins, M. B., Bedke, J., Alekseev, B., Wang, J. & 8 others, Mariani, M., Robbins, P. B., Chudnovsky, A., Fowst, C., Hariharan, S., Huang, B., Di Pietro, A. & Choueiri, T. K., 21 Mar 2019, In : New England Journal of Medicine. 380, 12, p. 1103-1115 13 p.

Research output: Contribution to journalArticle

340 Citations (Scopus)
1 Citation (Scopus)

Bone metastases in hypernephroma. Frequency of scapular involvement

Gurney, H., Larcos, G., McKay, M., Kefford, R. & Langlands, A., 1989, In : Cancer. 64, 7, p. 1429-1431 3 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)

Cabazitaxel in patients with metastatic castration-resistant prostate cancer: safety and quality of life data from the Australian early access program

Parente, P., Ng, S., Parnis, F., Guminski, A. & Gurney, H., Dec 2017, In : Asia-Pacific Journal of Clinical Oncology. 13, 6, p. 391-399 9 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: Effective treatment of patients with poor prognostic features

Shannon, C., Crombie, C., Brooks, A., Lau, H., Drummond, M. & Gurney, H., 2001, In : Annals of Oncology. 12, 7, p. 947-952 6 p.

Research output: Contribution to journalArticle

45 Citations (Scopus)

Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer

Lee, C. K., Gurney, H., Brown, C., Sorio, R., Donadello, N., Tulunay, G., Meier, W., Bacon, M., Maenpaa, J., Petru, E., Reed, N., Gebski, V., Pujade-Lauraine, E., Lord, S., Simes, R. J. & Friedlander, M., 26 Jul 2011, In : British Journal of Cancer. 105, 3, p. 360-365 6 p.

Research output: Contribution to journalArticle

21 Citations (Scopus)

Cardiovascular toxicity of targeted therapies for cancer: a protocol for an overview of systematic reviews

Van Leeuwen, M. T., Luu, S., Gurney, H., Brown, M. R., Webber, K., Pearson, S-A., Hunt, L. & Vajdic, C. M., 1 Jun 2018, In : BMJ Open. 8, 6, p. 1-6 6 p., e021064.

Research output: Contribution to journalArticle

Open Access
File
5 Downloads (Pure)

CheckMate 025 randomized Phase 3 study: outcomes by key baseline factors and prior therapy for nivolumab versus everolimus in advanced renal cell carcinoma

Escudier, B., Sharma, P., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., Castellano, D., Gurney, H., Donskov, F., Peltola, K., Wagstaff, J., Gauler, T. C., Ueda, T., Zhao, H., Waxman, I. M., Motzer, R. J. & 1 others, CheckMate 025 Investigators, 2017, In : European Urology. 72, 6, p. 962-971 10 p.

Research output: Contribution to journalArticle

105 Citations (Scopus)

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer

Lin, H. M., Castillo, L., Mahon, K. L., Chiam, K., Lee, B. Y., Nguyen, Q., Boyer, M. J., Stockler, M. R., Pavlakis, N., Marx, G., Mallesara, G., Gurney, H., Clark, S. J., Swarbrick, A., Daly, R. J. & Horvath, L. G., 13 May 2014, In : British Journal of Cancer. 110, 10, p. 2462-2471 10 p.

Research output: Contribution to journalArticle

80 Citations (Scopus)

Communicating risk in active surveillance of localised prostate cancer: A protocol for a qualitative study

Rapport, F., Hogden, A., Gurney, H., Gillatt, D., Bierbaum, M., Shih, P. & Churruca, K., 1 Oct 2017, In : BMJ Open. 7, 10, p. 1-7 7 p., e017372.

Research output: Contribution to journalArticle

Open Access
File
6 Downloads (Pure)

Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: Updated analysis of a randomized trial

Grimison, P. S., Stockler, M. R., Thomson, D. B., Olver, I. N., Harvey, V. J., Gebski, V. J., Lewis, C. R., Levi, J. A., Boyer, M. J., Gurney, H., Craft, P., Boland, A. L., Simes, R. J. & Toner, G. C., 18 Aug 2010, In : Journal of the National Cancer Institute. 102, 16, p. 1253-1262 10 p.

Research output: Contribution to journalArticle

45 Citations (Scopus)

Continuing cabazitaxel beyond 10 cycles for metastatic castrate-resistant prostate cancer: is there a benefit?

Al-Mansouri, L., Arasaratnam, M. & Gurney, H., 14 Jun 2019, In : European Journal of Hospital Pharmacy.

Research output: Contribution to journalArticle

Continuous infusion of vincristine, ifosfamide and epirubicin over 6 weeks in treatment-resistant advanced breast cancer

Gurney, H., Harnett, P., Stuart-Harris, R. & Kefford, R., 1995, In : European Journal of Cancer. 31, 11, p. 1773-1777 5 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Cure in advanced renal cell cancer: Is it an achievable goal?

Sabanathan, D., Park, J. J., Marquez, M., Francisco, L., Byrne, N. & Gurney, H., 1 Dec 2017, In : Oncologist. 22, 12, p. 1470-1477 8 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

CYP3A5 genotype and midazolam clearance in Australian patients receiving chemotherapy

Wong, M., Balleine, R. L., Collins, M., Liddle, C., Clarke, C. L. & Gurney, H., Jun 2004, In : Clinical Pharmacology and Therapeutics. 75, 6, p. 529-538 10 p.

Research output: Contribution to journalArticle

76 Citations (Scopus)

Cytoreductive nephrectomy for metastatic renal cell carcinoma: inequities in access exist despite improved survival

Patel, M. I., Beattie, K., Bang, A., Gurney, H. & Smith, D. P., Oct 2017, In : Cancer Medicine. 6, 10, p. 2188–2193 6 p.

Research output: Contribution to journalArticle

Open Access
File
14 Citations (Scopus)
2 Downloads (Pure)

Describing patterns of care in pancreatic cancer a population-based study: a population-based study

Burmeister, E. A., OʼConnell, D. L., Beesley, V. L., Goldstein, D., Gooden, H. M., Janda, M., Jordan, S. J., Merrett, N. D., Payne, M. E., Wyld, D. K., Neale, R. E. & Pancreatic Cancer Patterns of Care Study Group, Nov 2015, In : Pancreas. 44, 8, p. 1259-65 7 p.

Research output: Contribution to journalArticle

27 Citations (Scopus)

Doctor-patient communication: a study of Australian ethnic urological cancer patients

Cerimagic, S., Ahmadi, N., Gurney, H. & Patel, M. I., 1 Jun 2015, In : International Journal of Human Rights in Healthcare. 8, 2, p. 82-91 10 p.

Research output: Contribution to journalArticle

Dose escalation of tamoxifen in patients with low endoxifen level: Evidence for therapeutic drug monitoring - The TADE study

Fox, P., Balleine, R. L., Lee, C., Gao, B., Balakrishnar, B., Menzies, A. M., Yeap, S. H., Ali, S. S., Gebski, V., Provan, P., Coulter, S., Liddle, C., Hui, R., Kefford, R., Lynch, J., Wong, M., Wilcken, N. & Gurney, H., 1 Jul 2016, In : Clinical Cancer Research. 22, 13, p. 3164-3171 8 p.

Research output: Contribution to journalArticle

31 Citations (Scopus)

Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring

Sabanathan, D., Zhang, A., Fox, P., Coulter, S., Gebski, V., Balakrishnar, B., Chan, M., Liddle, C. & Gurney, H., Aug 2017, In : Cancer Chemotherapy and Pharmacology. 80, 2, p. 385–393 9 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)

Environmental and genetic factors affecting transport of imatinib by OATP1A2

Eechoute, K., Franke, R. M., Loos, W. J., Scherkenbach, L. A., Boere, I., Verweij, J., Gurney, H., Kim, R. B., Tirona, R. G., Mathijssen, R. H. J. & Sparreboom, A., 2011, In : Clinical Pharmacology and Therapeutics. 89, 6, p. 816-820 5 p.

Research output: Contribution to journalArticle

40 Citations (Scopus)

e-TC: development and pilot testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancer

Heiniger, L. E., Smith, A. B., Olver, I., Grimison, P., Klein, B., Wootten, A., Abbott, J-A. M., Price, M. A., McJannett, M., Tran, B., Stockler, M. R., Gurney, H. & Butow, P. N., Nov 2017, In : European Journal of Cancer Care. 26, 6, p. 1-10 10 p., e12698.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Evaluating bioanalytical capabilities of paper spray ionization for abiraterone drug quantification in patient plasma

Bhatnagar, A., McKay, M. J., Arasaratnam, M., Crumbaker, M., Gurney, H. & Molloy, M. P., 31 May 2020, (Accepted/In press) In : Journal of Mass Spectrometry.

Research output: Contribution to journalArticle

Factors affecting epirubicin pharmacokinetics and toxicity: Evidence against using body-surface area for dose calculation

Gurney, H. P., Ackland, S., Gebski, V. & Farrell, G., Jul 1998, In : Journal of Clinical Oncology. 16, 7, p. 2299-2304 6 p.

Research output: Contribution to journalArticle

100 Citations (Scopus)

Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma

Gurney, H., Crowther, D., Anderson, H., Murphy, D., Prendiville, J., Ranson, M., Mayor, P., Swindell, R., Buckley, C. H. & Tindall, V. R., Nov 1990, In : Annals of Oncology. 1, 6, p. 427-433 7 p.

Research output: Contribution to journalArticle

47 Citations (Scopus)

Functional analysis of novel polymorphisms in the human SLCO1A2 gene that encodes the transporter OATP1A2

Zhou, F., Zheng, J., Zhu, L., Jodal, A., Cui, P. H., Wong, M., Gurney, H., Church, W. B. & Murray, M., 2013, In : AAPS Journal. 15, 4, p. 1099-1108 10 p.

Research output: Contribution to journalArticle

28 Citations (Scopus)

Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer

Gao, B., Lu, Y., Nieuweboer, A. J. M., Xu, H., Beesley, J., Boere, I., De Graan, A. J. M., De Bruijn, P., Gurney, H., Kennedy, C. J., Chiew, Y. E., Johnatty, S. E., Beale, P., Harrison, M., Luccarini, C., Conroy, D., Mathijssen, R. H. J., Harnett, P. R., Balleine, R. L., Chenevix-Trench, G. & 2 others, MacGregor, S. & De Fazio, A., 1 Dec 2018, In : Scientific Reports. 8, 1, p. 1-10 10 p., 1508.

Research output: Contribution to journalArticle

Open Access
File
1 Citation (Scopus)
14 Downloads (Pure)

Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial

Pettengell, R., Gurney, H., Radford, J. A., Deakin, D. P., James, R., Wilkinson, P. M., Kane, K., Bentley, J. & Crowther, D., 1992, In : Blood. 80, 6, p. 1430-1436 7 p.

Research output: Contribution to journalArticle

376 Citations (Scopus)

Haemopoietic cell kinetics in humans treated with rGM‐CSF

Lord, B. I., Gurney, H., Chang, J., Thatcher, N., Crowther, D. & Dexter, T. M., 1992, In : International Journal of Cancer. 50, 1, p. 26-31 6 p.

Research output: Contribution to journalArticle

62 Citations (Scopus)

Health-related quality-of-life analysis from KEYNOTE-045: a phase III study of pembrolizumab versus chemotherapy for previously treated advanced urothelial cancer

Vaughn, D. J., Bellmunt, J., Fradet, Y., Lee, J. L., Fong, L., Vogelzang, N. J., Climent, M. A., Petrylak, D. P., Choueiri, T. K., Necchi, A., Gerritsen, W., Gurney, H., Quinn, D. I., Culine, S., Sternberg, C. N., Mai, Y., Li, H., Perini, R. F., Bajorin, D. F. & de Wit, R., 1 Jun 2018, In : Journal of Clinical Oncology. 36, 16, p. 1579-1587 12 p.

Research output: Contribution to journalArticle

27 Citations (Scopus)

Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer

Wong, M., Evans, S., Rivory, L. P., Hoskins, J. M., Mann, G. J., Farlow, D., Clarke, C. L., Balleine, R. L. & Gurney, H., Jan 2005, In : Clinical Pharmacology and Therapeutics. 77, 1, p. 33-42 10 p.

Research output: Contribution to journalArticle

56 Citations (Scopus)

High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation

Nath, C. E., Trotman, J., Tiley, C., Presgrave, P., Joshua, D., Kerridge, I., Kwan, Y. L., Gurney, H., McLachlan, A. J., Earl, J. W., Nivison-Smith, I., Zeng, L. & Shaw, P. J., Jul 2016, In : British Journal of Clinical Pharmacology. 82, 1, p. 149-159 11 p.

Research output: Contribution to journalArticle

20 Citations (Scopus)

Home or hospital? An evaluation of the costs, preferences, and outcomes of domiciliary chemotherapy

King, M. T., Hall, J., Caleo, S., Gurney, H. P. & Harnett, P. R., 2000, In : International Journal of Health Services. 30, 3, p. 557-579 23 p.

Research output: Contribution to journalArticle

35 Citations (Scopus)

How to calculate the dose of chemotherapy

Gurney, H., 22 Apr 2002, In : British Journal of Cancer. 86, 8, p. 1297-1302 6 p.

Research output: Contribution to journalArticle

157 Citations (Scopus)

Hypercalcaemia in small cell lung cancer: Report of a case associated with parathyroid hormone-related protein (PTHrP)

Stuart-Harris, R., Ahern, V., Danks, J. A., Gurney, H. & Martin, T. J., 1993, In : European Journal of Cancer. 29, 11, p. 1601-1604 4 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)